Literature DB >> 20211224

Identification of Wnt family inhibitors: a pituitary tumor directed whole genome approach.

Marianne S Elston1, Roderick J Clifton-Bligh.   

Abstract

Wnt signaling pathways are important regulators of normal embryological development including that of the pituitary gland. Altered Wnt pathway expression is common in many human tumors however until recently the role of these pathways in human pituitary tumorigenesis has received little attention. The advent of microarray analysis has identified several Wnt pathway inhibitors that are frequently perturbed in pituitary tumors. In this review we summarize the role of these inhibitors in other human tumor types and review the current state of knowledge of Wnt inhibitor expression in pituitary tumors. 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211224     DOI: 10.1016/j.mce.2010.02.039

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  8 in total

1.  Crystallization and preliminary X-ray crystallographic analysis of the sclerostin-neutralizing Fab AbD09097.

Authors:  Verena Boschert; Eva Maria Muth; Achim Knappik; Christian Frisch; Thomas D Mueller
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-03-20       Impact factor: 1.056

Review 2.  Secreted and transmembrane wnt inhibitors and activators.

Authors:  Cristina-Maria Cruciat; Christof Niehrs
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

3.  Wnt/β-Catenin Signaling Pathway Inhibitors: A Promising Cancer Therapy.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2014-07-09       Impact factor: 4.345

4.  Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training.

Authors:  Reina Armamento-Villareal; Corinn Sadler; Nicola Napoli; Krupa Shah; Suresh Chode; David R Sinacore; Clifford Qualls; Dennis T Villareal
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

5.  Effects of fulvestrant on biological activity and Wnt expression in rat GH3 cells.

Authors:  Jiwei Bai; Yan Wang; Chuzhong Li; Yazhuo Zhang
Journal:  Neural Regen Res       Date:  2012-02-05       Impact factor: 5.135

6.  Gremlin, a bone morphogenetic protein antagonist, is a crucial angiogenic factor in pituitary adenoma.

Authors:  Kenta Koketsu; Daizo Yoshida; Kyongsong Kim; Yudo Ishii; Shigeyuki Tahara; Akira Teramoto; Akio Morita
Journal:  Int J Endocrinol       Date:  2015-03-05       Impact factor: 3.257

7.  Screening for germline KCNQ1 and KCNE2 mutations in a set of somatotropinoma patients.

Authors:  Anna-Pauliina Iivonen; Johanna Känsäkoski; Atte Karppinen; Leena Kivipelto; Camilla Schalin-Jäntti; Auli Karhu; Taneli Raivio
Journal:  Endocr Connect       Date:  2018-05       Impact factor: 3.335

Review 8.  Efficacy of transsphenoidal surgery for pituitary tumor: A protocol for systematic review.

Authors:  Wei-Feng Wang; Lin-Hong Yang; Lin Han; Ming-Jun Li; Jian-Qi Xiao
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.